Current research and clinical data demonstrate that NK cell therapy, with its advantages of high specificity, high safety and no obvious adverse reactions, has become a new direction for liver cancer treatment. It shows irreplaceable value especially in the treatment of intermediate and advanced liver cancer and liver cancer with high postoperative recurrence risk.

With the continuous development of technologies such as artificial intelligence, multi-modal image fusion, and real-time dose monitoring, the CyberKnife of the future will have a higher level of intelligence. Its faster image processing speed, more accurate motion prediction models, and more adaptive treatment plan adjustments will allow this "radiation therapy drone" to cope freely on the anti-cancer battlefield, bringing patients safer, more efficient, and non-invasive new

Precision Treatment Becomes a New Trend Mr. Jiang’s case is a microcosm of the Department of Cardiology at Shulan Hospital exploring precision treatment for cardiovascular diseases. In recent years, with the development of medical technology, the treatment of cardiovascular diseases has evolved from traditional "symptomatic treatment" to the "targeted treatment era," bringing new hope to more patients.

Unlike traditional radiotherapy, which employs X-rays or gamma rays, proton beams exhibit a unique energy deposition pattern in matter. They deliver a lower dose as they enter the body and release most of their energy at a specific depth, known as the Bragg Peak. This Bragg Peak effect allows proton therapy to precisely concentrate a higher radiation dose on the tumor while minimizing damage to surrounding healthy tissues, achieving targeted "precision bombing" to cancer cell